Uterine Bleeding Clinical Trials

6 recruiting

Uterine Bleeding Trials at a Glance

16 actively recruiting trials for uterine bleeding are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Beijing, Bordeaux, and Cincinnati. Lead sponsors running uterine bleeding studies include Assiut University, Baylor College of Medicine, and Aesculap AG.

Browse uterine bleeding trials by phase

Treatments under study

About Uterine Bleeding Clinical Trials

Looking for clinical trials for Uterine Bleeding? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Uterine Bleeding trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Uterine Bleeding clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting
Not Applicable

Videos to Aid Decision Making for Fibroid Treatment

Decision AidUterine Bleeding
University of Pennsylvania154 enrolled1 locationNCT07072364
Recruiting
Not Applicable

Radiofrequency Endometrial Ablation or Uterine Artery Embolization for Treatment of Adenomyosis-related Abnormal Uterine Bleeding

Abnormal Uterine Bleeding Due to Adenomyosis (Disorder)
University Hospital, Bordeaux230 enrolled4 locationsNCT07195305
Recruiting

Endometrial Cancer Vaginal Fluid Specimen Collection Study

Endometrial CancerEndometrial Intraepithelial NeoplasiaAtypical Endometrial Hyperplasia+2 more
Exact Sciences Corporation4,200 enrolled1 locationNCT07544680
Recruiting
Not Applicable

The Effect of the Valsalva Maneuver in Endometrial Biopsy: A Randomized Controlled Trial

Abnormal Uterine BleedingPain in Endometrial Biopsy
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization120 enrolled1 locationNCT07496905
Recruiting
Not Applicable

The Effect of Uterine Manipulator Use During Abdominal Hysterectomy on Postoperative Sexual Function

Leiomyoma (Uterine Fibroids)Adenomyoma of UterusUterine Bleeding
Erkan Gol60 enrolled1 locationNCT07431788
Recruiting
Phase 1

Evaluation of Safety, Efficacy, and Pharmacokinetics of BT-114143 Injection in Patients With Abnormal Uterine Bleeding

Abnormal Uterine Bleeding
ScinnoHub Pharmaceutical Co., Ltd.39 enrolled1 locationNCT07169214
Recruiting

A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device

Abnormal Uterine BleedingHeavy Menstrual BleedingMenorrhagia
Channel Medsystems300 enrolled2 locationsNCT05922657
Recruiting
Phase 1

Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy

AnalgesiaAbnormal Uterine BleedingParacervical Block
Icahn School of Medicine at Mount Sinai60 enrolled1 locationNCT06653400
Recruiting
Not Applicable

Combined Hystroscopic and Laparoscopic Repair of CS Scar Disorder

Abnormal Uterine BleedingCesarean Section Complications
Assiut University30 enrolled1 locationNCT07183501
Recruiting
Not Applicable

Platelet Rich Plasma for Uterine Scar

Uterine BleedingPelvic PainCesarean Section Complications+1 more
The University of Texas Health Science Center, Houston40 enrolled1 locationNCT05224726
Recruiting

Ultrasound Transformation of Myomas During Relugolix-Estradiol-Norethisterone Treatment: The MySaturn Study

Uterine NeoplasmsUterine BleedingUterine Leiomyomas+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS111 enrolled1 locationNCT06953076
Recruiting

Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy

Ovarian CancerCervical CancerEndometrial Cancer+5 more
Aesculap AG132 enrolled2 locationsNCT06024109
Recruiting

Role of Laparoscopic Uterine Artery Clipping in Refractory Abnormal Uterine Bleeding Related to Benign Causes

gynecological bleedingirregular uterine bleeding due to benign caused
Maternity and children hospital faculty of medicine Minia University100 enrolled1 locationACTRN12624001424594
Recruiting
Phase 3

IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department

Uterine BleedingAnemia, Iron Deficiency
Baylor College of Medicine40 enrolled1 locationNCT05304442
Recruiting
Not Applicable

Impact of Single- Versus Double-layer Hysterotomy Closure on Cesarean Niche Development: a Randomized Controlled Trial

Uterine BleedingCesarean Section ComplicationsCesarean Section; Dehiscence+2 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico150 enrolled1 locationNCT06308172
Recruiting
Phase 3

Intrauterine Lidocaine versus Placebo in Conjunction with Paracervical Block for Pain Relief During Fractional Curettage: A Randomized Controlled Trial

Pain score in women with abnormal uterine bleeding who undergoing fractional and curettageAdverse effects in women with abnormal uterine bleeding who undergoing fractional and curettageAdditional drug requirement in women with abnormal uterine bleeding who undergoing fractional and curettage
Khon Kaen Hospital230 enrolled1 locationACTRN12611000449932